Amit K. Verma, MBBS, is a Professor in the Departments of Medicine (Oncology) and Development & Molecular Biology at Albert Einstein School of Medicine. Dr. Verma is the Director of the Division of Hemato-Oncology, Montefiore Department of Oncology. His primary area of research is in MDS.
Amer Zeidan, MBBS, MHS is an Associate Professor of Medicine (Hematology) at the Yale School of Medicine. Dr. Zeidan specializes in the management of MDS and acute myeloid leukemia (AML) and is an international expert in the clinical management and research of myeloid malignancies.
Dr. Verma and Dr. Zeidan will give an update on the two newest treatments for MDS patients, INQOVI and REBLOYZL. They will also give a brief update on what is in the immediate pipeline for MDS patients and what can be expected into 2021.
Participants will have an opportunity to ask questions via the text chat window. Those who are joining via telephone are invited to submit their questions to email@example.com in advance of the webinar.
Thank you for registering for "New and Emerging Therapies for MDS", September 30, 2020 at 3:00pm ET.
You will receive an email with a registration confirmation including the webinar link
and a call-in phone # for those participating via telephone. If you do not receive the link,
please check your Spam/Junk folders.
If you have not received a registration confirmation, please email firstname.lastname@example.org
or call (800) 747-2820 x2 no later than 30 minutes before the webinar is scheduled to begin.
If you are not able to join the webinar, an archived video will be available in 2 - 3 business days on the AAMDSIF website.